Whetton AD - Search Results

1

Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells.

Abraham SA, Hopcroft LE, Carrick E, Drotar ME, Dunn K, Williamson AJ, Korfi K, Baquero P, Park LE, Scott MT, Pellicano F, Pierce A, Copland M, Nourse C, Grimmond SM, Vetrie D, Whetton AD, Holyoake TL. Abraham SA, et al. Among authors: whetton ad. Nature. 2016 Jun 16;534(7607):341-6. doi: 10.1038/nature18288. Epub 2016 Jun 8. Nature. 2016. PMID: 27281222 Free PMC article.

2

Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patients.

Balabanov S, Evans CA, Abraham SA, Pellicano F, Copland M, Walker MJ, Whetton AD, Holyoake TL. Balabanov S, et al. Among authors: whetton ad. Proteomics. 2013 Jan;13(1):153-68. doi: 10.1002/pmic.201200022. Proteomics. 2013. PMID: 23184491

3

The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.

Pellicano F, Scott MT, Helgason GV, Hopcroft LE, Allan EK, Aspinall-O'Dea M, Copland M, Pierce A, Huntly BJ, Whetton AD, Holyoake TL. Pellicano F, et al. Among authors: whetton ad. Stem Cells. 2014 Sep;32(9):2324-37. doi: 10.1002/stem.1748. Stem Cells. 2014. PMID: 24806995 Free PMC article.

4

Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell lines.

Aspinall-O'Dea M, Pierce A, Pellicano F, Williamson AJ, Scott MT, Walker MJ, Holyoake TL, Whetton AD. Aspinall-O'Dea M, et al. Among authors: whetton ad. Nat Protoc. 2015 Jan;10(1):149-68. doi: 10.1038/nprot.2015.007. Epub 2014 Dec 18. Nat Protoc. 2015. PMID: 25521791

5

BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor.

Pierce A, Spooncer E, Ainsworth S, Whetton AD. Pierce A, et al. Among authors: whetton ad. Oncogene. 2002 May 2;21(19):3068-75. doi: 10.1038/sj.onc.1205424. Oncogene. 2002. PMID: 12082538

6

The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia.

Griffiths SD, Burthem J, Unwin RD, Holyoake TL, Melo JV, Lucas GS, Whetton AD. Griffiths SD, et al. Among authors: whetton ad. Mol Biotechnol. 2007 Jun;36(2):81-9. doi: 10.1007/s12033-007-0005-5. Mol Biotechnol. 2007. PMID: 17914187

7

Development of approaches for systematic analysis of protein networks in stem cells.

Williamson AJ, Whetton AD. Williamson AJ, et al. Among authors: whetton ad. Adv Enzyme Regul. 2010;50(1):273-84. doi: 10.1016/j.advenzreg.2009.10.028. Epub 2009 Nov 13. Adv Enzyme Regul. 2010. PMID: 19914280 No abstract available.

8

The requirement for proteomics to unravel stem cell regulatory mechanisms.

Williamson AJ, Whetton AD. Williamson AJ, et al. Among authors: whetton ad. J Cell Physiol. 2011 Oct;226(10):2478-83. doi: 10.1002/jcp.22610. J Cell Physiol. 2011. PMID: 21792904 Review.

9

The use of proteomics for systematic analysis of normal and transformed hematopoietic stem cells.

Cadeco S, Williamson AJ, Whetton AD. Cadeco S, et al. Among authors: whetton ad. Curr Pharm Des. 2012;18(13):1730-50. doi: 10.2174/138161212799859675. Curr Pharm Des. 2012. PMID: 22397328 Review.

10

BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response.

Griaud F, Williamson AJ, Taylor S, Potier DN, Spooncer E, Pierce A, Whetton AD. Griaud F, et al. Among authors: whetton ad. J Proteomics. 2012 Dec 21;77:14-26. doi: 10.1016/j.jprot.2012.06.003. Epub 2012 Jun 15. J Proteomics. 2012. PMID: 22705319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page